Yong Park, MD
Pain Medicine · Fairless Hills, PANPI 1154368819
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,195 of the $7,147 with a category attached, or 72.7%. 22 manufacturers reported payments, led by Medtronic at 40.2% of the total. 2025 is the largest year on record at $2,505, 4.9 times the $507 reported in 2019.
Across 191 payments — averaging $37.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- Abbott$1K
- Scilex Pharmaceuticals Inc.$414
- Ipsen Biopharmaceuticals, Inc$283
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$135
- plus $560 from 16 others
What the payments were for
- Travel & lodging$1,95227%
- Food & beverage$5,19573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 57 | $2,870 |
| Boston Scientific | 24 | $1,656 |
| Abbott | 48 | $1,228 |
| Scilex Pharmaceuticals Inc. | 21 | $414 |
| Ipsen Biopharmaceuticals, Inc | 9 | $283 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $135 |
| Nevro Corp. | 3 | $59 |
| Si-bone, Inc. | 2 | $53 |
| Appliedvr Inc | 2 | $49 |
| IBSA Pharma Inc. | 2 | $48 |
| Globus Medical | 2 | $48 |
| Saluda Medical Americas, Inc. | 1 | $46 |
| International Rehabilitative Sciences, Inc | 1 | $39 |
| Biotronik NRO, Inc. | 1 | $39 |
| Relievant Medsystems, Inc. | 1 | $34 |
| Saol Therapeutics Inc. | 3 | $34 |
| Redhill Biopharma Inc. | 2 | $33 |
| Foundation Fusion Solutions, LLC | 1 | $24 |
| Novartis | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| SPR Therapeutics, Inc | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,170
- Intracept$560
- INCEPTIV$258
- DYSPORT$103
How this compares
$7,147 in reported general payments places this provider in the 80th percentile of 294 pain medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 21 | $11,599 |
| MovantikNaloxegol Oxalate | 20 | $8,199 |
| Fentanyl | 38 | $5,960 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 202 | $5,238 |
| Lidocaine | 18 | $4,887 |
| Gabapentin | 279 | $4,096 |
| ZtlidoLidocaine | 11 | $3,912 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 128 | $3,370 |
| Oxycodone Hcl | 186 | $3,101 |
| Tramadol Hcl ErTramadol Hcl | 37 | $3,031 |
| Pregabalin | 78 | $1,443 |
| Tramadol Hcl | 174 | $1,337 |
| Buprenorphine | 12 | $1,210 |
| Morphine Sulfate ErMorphine Sulfate | 51 | $1,187 |
| Tizanidine Hcl | 74 | $959 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $33 | $8,19920 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $414 | $3,91211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 294 pain medicine providers in Pennsylvania.
Other pain medicine in Fairless Hills
- Peter PryzbylkowskiPhiladelphia$506K
- Yeshvant NavalgundGreensburg$388K
- Jack SmithWilliamsport$324K
- Sanjay GuptaBala Cynwyd$241K
- Vwaire OrhurhuWilliamsport$191K
- Philip KimBryn Mawr$128K
- Ajay WasanPittsburgh$66K
- Sanjay ShahSpring House$64K
- Soon JungAllentown$58K
- Bruce NicholsonAllentown$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.